Connect
← Return to Significant osteoporosis: I need a bone plan
Discussion
Significant osteoporosis: I need a bone plan
Osteoporosis & Bone Health | Last Active: 21 hours ago | Replies (110)Comment receiving replies
@hollygs, you're right. There is a brief period where new members can't post links. We do this to deter spammers and keep the community safe. You will be able to add URLs to your posts in a few days. Allow me to add the link to the Mayo article that you wanted to share with @windyshores
- Beyond bone density: Checking the health of your bone https://mcpress.mayoclinic.org/living-well/beyond-bone-density-checking-the-health-of-your-bones/
Replies to "@hollygs, you're right. There is a brief period where new members can't post links. We do..."
@colleenyoung Thank you so much, I appreciate your reply and inclusion of the link.
Colleen,
Can you tell me how to create a new thread in this osteoporosis arena? I am newly diagnosed with Osteoporosis. My endocrinologist ordered blood work and a 24-hour calcium test. I have a question regarding the Calcium 24-hour urine with creatinine test she ordered (LabCorp code: 003324). I thought I was supposed to collect urine for 24 hours, but when I went to LabCorp to pick up the collection jug, I received 2 jugs and was told it was for two tests: 24 hours urine collection for the first jug, then another 24 hours collection for the second jug (containing Hydrochloric acid). Is that right?
Connect
THanks @colleenyoung. @hollygs this article states that markers (all markers?) increase on Forteo and Tymlos. This is what I usually see. That other article that I posted above is the first time I have seen something more complex. Interesting that this article says bone markers are not useful when on anabolics since so many here on the forum are using them with Forteo and Tymlos to see if they are working, (I do have kidney disease so I don't use the CTX...) So confusing! Here is an excerpt:
"BTMs are not of much help in monitoring people on anabolic therapy. Anabolic therapies — such as teriparatide (Forteo), abaloparatide (Tymlos) and romosozumab (Evenity) — work by stimulating bone formation, which leads to increases in bone mass and density. Since new bone is being built, the markers are expected to increase and are not helpful in the decision-making process. There is also no role for monitoring after completion of anabolic treatment, as all these agents should be followed by treatment with anti-resorptive drugs without a pause in treatment."